malondialdehyde has been researched along with Angina, Stable in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujita, H; Ito, T; Ohte, N; Seo, Y; Sugiura, T; Yokoi, M | 1 |
| Ai, Y; Dong, H; Wang, J; Xu, L; Zhang, Q | 1 |
| Fujita, H; Ito, T; Ohte, N; Tani, T | 1 |
| Gorokhova, VG; Koryakina, LB; Kuril'skaya, TE; Kuznetsova, EE; Pivovarov, YI | 1 |
| Lee, JH; Leibundgut, G; Segev, A; Strauss, BH; Tsimikas, S | 1 |
1 trial(s) available for malondialdehyde and Angina, Stable
| Article | Year |
|---|---|
Acute and long-term effect of percutaneous coronary intervention on serially-measured oxidative, inflammatory, and coagulation biomarkers in patients with stable angina.
Topics: Angina, Stable; Biomarkers; C-Reactive Protein; Cohort Studies; Female; Humans; Inflammation Mediators; Interleukin-6; Lipids; Male; Malondialdehyde; Middle Aged; Percutaneous Coronary Intervention; Plasminogen; Tissue Plasminogen Activator | 2016 |
4 other study(ies) available for malondialdehyde and Angina, Stable
| Article | Year |
|---|---|
Increased Serum Malondialdehyde-Modified Low-Density Lipoprotein and Coronary Angiographic Progression After Drug-Eluting Stent Implantation in Patients With Stable Angina.
Topics: Aged; Aged, 80 and over; Angina, Stable; Biomarkers; Coronary Angiography; Coronary Artery Disease; Disease Progression; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Japan; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Percutaneous Coronary Intervention; Plaque, Atherosclerotic; Retrospective Studies | 2020 |
Circulating Oxidized Low-Density Lipoprotein is a Strong Risk Factor for the Early Stage of Coronary Heart Disease.
Topics: Aged; Angina, Stable; Angina, Unstable; Apolipoproteins A; Apolipoproteins B; Biomarkers; C-Reactive Protein; Case-Control Studies; Cholesterol, HDL; Cholesterol, LDL; Coronary Angiography; Coronary Artery Disease; Female; Humans; Lipoprotein(a); Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Myocardial Infarction; Risk Factors | 2019 |
Malondialdehyde-modified low-density lipoprotein is a predictor of cardiac events in patients with stable angina on lipid-lowering therapy after percutaneous coronary intervention using drug-eluting stent.
Topics: Aged; Angina, Stable; Atherosclerosis; Drug-Eluting Stents; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Multivariate Analysis; Myocardial Infarction; Percutaneous Coronary Intervention; Prognosis; Proportional Hazards Models; Reperfusion Injury; Retrospective Studies; Risk Factors; ROC Curve; Treatment Outcome | 2015 |
Role of Endogenous Factors in Response of Erythrocyte Membrane in Patients with Cardiovascular Diseases under Conditions of Ischemic Exposure.
Topics: Adsorption; Adult; Angina, Stable; Arm; Blood Viscosity; Brachial Artery; Constriction; Coronary Disease; Erythrocyte Membrane; Fibrinogen; Hemoglobins; Humans; Ischemia; Lipids; Male; Malondialdehyde; Middle Aged; Nucleotides; Plasminogen; Platelet Adhesiveness; von Willebrand Factor | 2015 |